MANDRIA FUQUA: Open Payments
NPI 1760483697 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 24 payments from 15 companies in 2025. Trend: 2023 $798 · 2024 $852 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $95 |
| Amgen Inc. | 3 | $43 |
| ABBVIE INC. | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| Inspire Medical Systems, Inc. | 2 | $35 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| Exact Sciences Corporation | 1 | $30 |
| Abbott Laboratories | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: Wegovy, QULIPTA, INSPIRE, PURIFIED CORTROPHIN GEL, The Cologuard Plus Collection Kit, OTEZLA, Ozempic, FREESTYLE LIBRE 3.
Industry payments across VA — which companies pay providers there.
